Will publish

TRANSFUSION MEDICINE REVIEWS Will Publish in Future Issues . . . David Asher: Diagnostic tests for the TSEs John Barbara: Approaches to transmissible test kit evaluation Keith Berman: Where the money is: Third-party payment for the costs of universal leukoreduction in the United States Mo Blajchman: Improving the bacteriological safety of platelet transfusions Zenon Bodnaruk: The current Jehovah Witnesses’ position on the use of blood components and fractions John Chapman: Inactine technology for the viral inactivation of cellular blood products Frans Claas: Possible mechanisms and clinical applications of immunomodulation by blood transfusion Trevor J. Cobain: Fresh blood product manufacture, issue, and use: A chain of diminishing returns? Greg Denomme: The structure and function of the alloantigens on red blood cells and platelets Joy Fridey: Home transfusion therapy George Garratty: Modulation of RBC antigens Ray Goodrich and Bob Schuyler: Pathogen inactivation of platelets using Riboflavin Catherine Hayward: The treatment of inherited fibrinolytic states Nancy Heddle: Statistics for transfusion medicine Leslie Holness: Transfusion-associated fatalities in the United States: 1990-2000 Louis Katz and Paul Cumming: Computer-based donor screening questionnaire: A status report Phil Kiely and Erica Wood: Biological false reactive samples and blood donor management continued . . .

TR ANSFUSION MEDICINE REVIEWS Will Publish in Future Issues . . . continued . . . K. Lankford-Hillyer and C.D. Hillyer: Leukoreduction and sickle trait blood David A. Leiby: Transfusion-transmitted tick infections James S. Malter: Recent development on cellular-based immunotherapy of cancer and relevant challenges for transfusion medicine Leo J. McCarthy: History of the evolution of transfusion practice Mohandas Narla: The structure of the red cell membrane Lars Nielson: Bioreactors for hematopoietic cell culture Lawrence D. Petz: Bystander immune cytolysis Lawrence D. Petz: Hemolysis associated with transplantation Man-Chui Poon: Factor VIIa for the treatment of thrombocytopenia and platelet function disorders Glenn Ramsey: Managing blood product recalls and withdrawals Henk W. Reesink: HTLV I/II prevalence in different geographic locations John Saldanha and Cecile Chaput: The risk of Parvovirus B19 transfusion transmission Sentot Santoso: Platelet alloantibodies and their clinical significance Merlyn Sayers and Laurie Sutor: Bioterrorism and blood banking George Schreiber: The REDS study: An overview and status report Clive Seed: Screening for malaria to avoid unnecessary blood donor deferral Sherrill J. Slichter: The platelet transfusion trigger Milli F. Stein: Recruitment of blood donors in an HIV endemic area Jill Storry: Nonmicrobiological applications of DNA analysis in transfusion medicine Joe Sweeney: Improving the potency of liquid-stored cellular blood products William Swiggard: Blood-borne pathogens and their vulnerabilities Francesco Torella: The role of hospital transfusion committees in blood-product conservation

TR ANSFUSION MEDICINE REVIEWS Will Publish in Future Issues . . . continued . . . Stephen Vamvakas: Is leukoreduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A meta-analysis and review of the statistical considerations Pieter van der Meer: New developments in the preparation of blood components Ted Warkentin: The syndrome of venous gangrene Richard Weiskopf: Memory and cognitive function associated with anemia and its reversibility Sue Whittaker: Qualitative research in transfusion medicine Gordon Whyte: Risk assessment and management in transfusion medicine Lorna Williamson and Elizabeth Love: Serious hazards of transfusion in the UK: Four year’s experience with the SHOT program